Skip to main content
. Author manuscript; available in PMC: 2011 Mar 29.
Published in final edited form as: Pediatr Res. 2009 Aug;66(2):155–161. doi: 10.1203/PDR.0b013e3181aa07eb

Table 1.

Real Time polymerase chain reaction measurements of genes involved with ductus closure and remodeling: ductus obtained from 19d gestation fetuses.

ΔCT(MDH-gene) ΔCT(MDH-gene)
Gene Control COX
Inhibition
P Gene Control COX
Inhibition
P
mean sd mean sd mean sd mean sd
Ca++ L-channels Vasodilation
CaLα1c −2.33 ±0.52 −3.09 ±0.31 * COX1 −5.34 ±0.37 −5.29 ±0.69
CaLβ2 −2.52 ±0.34 −3.26 ±0.53 * COX2 −5.53 ±0.58 −4.75 ±0.89
CaLβ3 −2.71 ±0.41 −3.48 ±0.52 * eNOS −8.86 ±0.91 −9.68 ±1.43
EP2 −8.16 ±1.00 −7.76 ±0.36
K+ channels EP3 −5.46 ±0.27 −5.63 ±0.62
BKCa −9.34 ±0.93 −7.99 ±1.31 EP4 −0.20 ±1.20 −0.71 ±0.87
BKCaβ1 −3.70 ±0.52 −4.30 ±0.36 * HO1 −3.52 ±0.31 −1.48 ±0.97 *
Kir6.1 −2.44 ±0.72 −3.52 ±0.87 * HO2 −2.51 ±0.42 −2.51 ±0.28
SUR2 −3.21 ±0.43 −3.63 ±0.61 PDE1A −5.22 ±0.40 −5.89 ±0.19 *
Kv1.2 −4.68 ±0.53 −4.99 ±0.76 PDE1B −2.52 ±1.03 −2.83 ±0.48
Kv1.5 −3.11 ±0.36 −3.99 ±0.48 * PDE3A −2.38 ±0.28 −3.41 ±0.54 *
Kv2.1 −3.53 ±0.83 −3.69 ±0.71 PDE3B −2.80 ±0.52 −3.05 ±0.13
Kv9.3 −1.47 ±0.41 −2.18 ±0.53 PDE4D −6.22 ±0.69 −6.51 ±0.30
Kvβ1.2 −3.96 ±0.63 −4.36 ±0.36 PDE5A −2.75 ±0.36 −3.26 ±0.55
Kvβ1.3 −1.96 ±0.36 −2.29 ±0.27
Remodeling
Contractility Ang−1 −4.44 ±0.54 −4.76 ±0.36
Caldesmon −0.03 ±0.21 −0.76 ±0.41 * Ang-2 −5.91 ±0.47 −5.82 ±0.74
Calponin −1.58 ±0.55 −2.01 ±0.49 ATIIR-1 −4.96 ±0.72 −5.08 ±0.45
Myocardin −3.17 ±0.38 −3.97 ±0.31 * HAS2 −4.69 ±0.45 −4.99 ±0.19
MYH1 0.41 ±0.68 0.05 ±0.81 HIF1α −3.75 ±0.87 −3.99 ±0.25
MYH2 −1.97 ±0.93 −2.34 ±0.48 HIF2α −2.71 ±0.66 −2.76 ±0.44
RhoA −0.94 ±0.74 −0.80 ±0.44 IFNγ −3.07 ±0.54 −3.18 ±0.25
RhoB −2.36 ±0.27 −2.87 ±0.51 IL6 −3.66 ±0.37 −4.06 ±0.26
ROCK1 −4.02 ±0.81 −4.27 ±0.64 PDGF-B −5.06 ±0.45 −5.19 ±0.54
NCX1 −4.29 ±0.95 −4.92 ±0.60 Tenascin-C −1.60 ±0.30 −2.13 ±0.36 *
PHLBN −2.88 ±0.68 −2.98 ±0.51 TFAP2b −4.81 ±1.34 −5.36 ±1.05
SERCA3 −6.58 ±0.42 −6.64 ±0.23 TGFβ1 −4.17 ±0.37 −4.67 ±0.29 *
Tropomyosin −3.00 ±0.39 −3.80 ±0.54 * TGFβ3 −2.71 ±0.23 −3.43 ±0.21 *
TNFα −2.38 ±1.00 −2.69 ±0.29
Endothelin TRAF1 −5.96 ±1.05 −6.31 ±0.53
ECE1 −1.18 ±0.68 −1.86 ±0.26 VEGF −3.57 ±0.50 −2.78 ±0.42 *
ET1 −4.43 ±0.95 −4.55 ±0.62
ETAr −5.99 ±1.52 −6.27 ±1.67
ETBr −2.66 ±0.79 −2.77 ±0.37

ΔCT(MDH-gene) = difference in cycle threshold (CT) between the expression of the housekeeping gene Malate dehydrogenase (MDH) and the gene of interest. Each unit of ΔCT(MDH-gene) represents a 2-fold increase in a gene’s mRNA. The more negative the ΔCT(MDH-gene), the fewer the number of starting copies of a gene (mRNA). Number of separate litters used: Control (day 19) = 9, COX-inhibition (days 15–19) = 7. From each litter of mice we obtained and pooled between 10–12 ductus.

*

p<0.05.

MYH, myosin heavy chain; ROCK1, Rho kinase 1; NCX1, Na+/Ca++ exchanger; PHLBN, phospholamban; SERCA, sarcoplasmic reticulum Ca++-ATPase; ECE, endothelin converting enzyme; ET, endothelin; ETAr, endothelin receptor A; eNOS, endothelial nitric oxide synthase; EP, prostaglandin E receptor; HO, heme oxygenase; PDE, phosphodiesterase; ang, angiopoietin; ATIIR-1, angiotensin II receptor; HAS, hyaluronic acid synthase; HIF, hypoxia inducible factor; IFN, interferon; IL, interleukin; PDGF, platelet derived growth factor.